Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atzeyo Biosensors is developing a point-of-care molecular diagnostic platform using PRAM technology to enable rapid, ultrasensitive detection of cancer biomarkers directly in the physician’s office. The company aims to provide lab-quality results with the speed and simplicity required for real-time clinical decision-making. As of late 2024/early 2025, the company remains pre-commercial with ongoing product development and initial seed funding secured[2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atzeyo Biosensors, Inc..